MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $99,000 | -57.1% | 79,599 | +5.9% | 0.00% | -100.0% |
Q1 2017 | $231,000 | -19.2% | 75,158 | +7.1% | 0.00% | 0.0% |
Q4 2016 | $286,000 | -99.9% | 70,183 | -0.3% | 0.00% | -50.0% |
Q3 2016 | $446,811,000 | +18.0% | 70,364 | +0.2% | 0.00% | 0.0% |
Q2 2016 | $378,685,000 | -29.7% | 70,257 | +9.0% | 0.00% | 0.0% |
Q1 2016 | $539,000,000 | +5.9% | 64,441 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $509,000,000 | +92614.0% | 64,441 | -0.2% | 0.00% | 0.0% |
Q3 2015 | $549,000 | -99.9% | 64,553 | +0.1% | 0.00% | -33.3% |
Q2 2015 | $797,246,000 | +8.7% | 64,476 | +4.4% | 0.00% | 0.0% |
Q1 2015 | $733,388,000 | +5.1% | 61,733 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $697,583,000 | +21.5% | 61,733 | -5.6% | 0.00% | 0.0% |
Q3 2014 | $574,001,000 | +22.6% | 65,376 | +1.8% | 0.00% | +50.0% |
Q2 2014 | $468,186,000 | +39.3% | 64,223 | -3.7% | 0.00% | 0.0% |
Q1 2014 | $336,188,000 | -3.3% | 66,704 | +2.4% | 0.00% | 0.0% |
Q4 2013 | $347,764,000 | +47.8% | 65,126 | +5.2% | 0.00% | +100.0% |
Q3 2013 | $235,248,000 | +233.7% | 61,910 | +491.1% | 0.00% | – |
Q2 2013 | $70,490,000 | – | 10,474 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |